Bioethanol Market Market Analysis

Feedstock (Starch-based, Sugar-based, Cellulose based)

Starch-based segment is anticipated to dominate over 52% bioethanol market share by 2037. The starch-based bioethanol segment’s growth can be attributed to the abundance of starch feedstocks, which provide a steady and dependable supply. According to the National Institutes of Health, sugar cane and sugar beet account for around 40% of the world's bioethanol production, whereas feedstocks containing starch account for approximately 60% of it. Moreover, the existing infrastructure and expertise for manufacturing and transporting ethanol provide similar advantages for starch-based bioethanol. Also, several countries have implemented methods and equipment for turning starch feedstocks into bioethanol. This system, which fosters a market for bioethanol made from starch, includes blending facilities, transportation networks, and ethanol plants.

Fuel Blend (E5, E10, E15 to E70, E75 to E85)

The E10 segment in bioethanol market is expected to garner a significant share by 2037. The segment is witnessing growth due to the various initiatives by several governments to enforce the use of E10 fuel mixes in cars. According to a report by the US Grains Council in 2022, the UK started transitioning its gasoline supply in September 2021 from an E5 basis to an E10 blend. The country currently consumes 280 million gallons of gasoline-ethanol or 7% of its total fuel blend. However, soon the region expects to reach a 9.7% ethanol blend.

End use (Transportation, Alcoholic Beverages, Cosmetics, Pharmaceuticals)

The pharmaceutical segment in bioethanol market is anticipated to gain a notable revenue share during the forecast period. The segment’s expansion can be attributed to the ability of bioethanol to improve the solubility of hydrophobic active pharmaceutical ingredients (APIs), as a result enhancing the bioavailability and efficacy of drugs. Moreover, bioethanol meets the strict regulatory criteria and quality standards implemented on pharmaceutical products, making it a recognized safe and compliant solvent for pharmaceutical applications. It is gaining momentum among drug producers because it offers safety and compliance with regulations.

Our in-depth analysis of the market includes the following segments: